Each week, the law firm d’Oliveira & Associates compiles a summary of recalls, FDA warnings, market withdrawals and safety alerts that the public should be aware of for their safety so they …
BioCryst Pharmaceuticals, Inc. (BCRX) announced Monday that the Public Health Institute (ISP) of Chile has granted marketing authorization for oral, once-daily ORLADEYO (berotralstat) for the prophylaxis of hereditary angioedema (HAE) attacks in patients 12 years of age or older.
Ford (F) reiterated its expectations for full-year 2023 adjusted EBIT of $9 billion to $11 billion and adjusted free cash flow of about $6 billion. The company continues to anticipate EBIT of about $7 billion for Ford Blue, up modestly from 2022, and approaching $6 billion for Ford Pro, nearly double last year, and a full-year loss of about $3 billion for the startup Ford Model e.
Consumers in the Netherlands continued to remain pessimistic in May as they became more negative about the economic climate, data from the Central Bureau of Statistics showed on Monday.